• Pharmacists Center

    The Pharmacists Center features helpful resources, links, and tools supporting healthcare provider and patient education as well as useful information for practicing oncology pharmacists. Pharmacists Center

  • Nurses Center

    The Nurses Center features helpful resources, links, and tools supporting nurse and patient education as well as the practice of oncology nursing. Nurses Center

  • Fellows Center

    The Fellows Center features helpful resources, links, and tools supporting oncology fellows' education and current clinical practice. Fellows Center

Leading in innovation by following the science

Acquired functional capabilities of cancer cells
Click here to view a larger version of this image

This figure was adapted with permission from Cell, Vol 100, Hanahan and Weinberg, The Hallmarks of Cancer, pp 57-70, Copyright Elsevier (2000).

While there are many distinct types of cancer, there are believed to be 6 essential alterations to normal cell physiology, which together define the progression of most human malignancies.1

Our goal at Genentech, a member of the Roche Group, is to investigate and develop innovative therapies that target the biologic mechanisms that give rise to cancer, with the hope of extending the lives of patients. Our scientists are dedicated to defining the molecular basis of cancer and to translating this knowledge into the development of novel biologic and small-molecule agents that target the ability of cancer cells to grow and spread.

Self-sufficiency in growth signals:
Cancer cells produce their own growth signals and proliferate without environmental cues1

Evading apoptosis:
Tumor cells avoid apoptosis (programmed cell death) and expand in number1

Sustained angiogenesis:
Cancer cells induce and sustain blood vessel growth1

Limitless potential for replication:
The DNA of tumor cells can replicate an infinite number of times1

Tissue invasion and metastasis:
Tumor masses spawn pioneer cells that colonize sites where nutrients and space are not limiting1

Insensitivity to antigrowth signals:
Cancer cells evade antigrowth signals in order to proliferate1

Next: Pipeline Clinical Trials